Return to program book search

Session Information

SYM S039 - Practical Approaches to Melanoma and Dysplastic Nevi

Open admission to eligible categories, no tuition or ticket

Subject:

Date: Monday, March 04

CME Credits: 3.00

Location: Flamingo 1/2

Time: 9:00 AM - 12:00 PM

Director: Michael E. Ming, MD, FAAD

Speakers:

  • M. Shane Chapman, MD, FAAD
  • James M. Grichnik, MD, PhD, FAAD - Handout
  • Allan C. Halpern, MD, FAAD
  • Timothy M. Johnson, MD, FAAD - Handout
  • Sancy A. Leachman, MD, PhD, FAAD
  • Beth S. Ruben, MD, FAAD
  • Kara N. Shah, MD, PhD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Manage patients with melanoma.
  • Counsel patients with melanoma.

Description:
Many of the important issues regarding the appropriate management of patients with dysplastic nevi or a history of melanoma are complex, such as who would benefit from genetic testing, which patients are appropriate candidates for sentinel lymph node mapping, and what the role is of imiquimod or BRAF inhibitors in melanoma treatment, yet these issues arise daily in practice. The emphasis of this session is on practical information that will help dermatologists refine their management of patients with melanocytic lesions.

Schedule:

Monday, March 04
9:00 AMShould Dysplastic Nevi Be Re-excised? / Dr. Grichnik
9:20 AMHow Should I Manage a Patient with a Pigmented Nail Band? / Dr. Ruben
9:40 AMHow Concerned Should I Be About Congenital Nevi in Terms of Melanoma Risk? / Dr. Shah
10:00 AMWhat Is the Role of Genetic Testing in Melanoma? / Dr. Leachman
10:20 AMQ & A / Dr. Grichnik, Dr. Ruben, Dr. Shah, and Dr. Leachman
10:30 AMCan Diagnostic Aids Such as Whole Body Photography and iPad Applications Help in the Diagnosis of Melanoma? / Dr. Halpern
10:50 AMIs There a Role for Imiquimod in the Treatment of Lentigo Maligna? / Dr. Chapman
11:10 AMWhich Melanoma Patients Might Be Candidates for Sentinel Node Mapping? / Dr. Johnson
11:30 AMWhat Should Dermatologists Know About the Newer Treatments for Metastatic Melanoma? / Dr. Ming
11:50 AMQ & A / Dr. Ming, Dr. Halpern, Dr. Chapman, and Dr. Johnson